Shane P. Kennedy is an experienced marketing professional currently serving as the Director and Head of Evobrutinib Marketing for U.S. Neurology & Immunology at EMD Serono, Inc., since November 2017. Prior roles at EMD Serono include Director of Marketing and Associate Director of Marketing within the same division. Shane's earlier experience includes various leadership positions at DDB Health, including Vice President and Account Supervisor, and roles such as Digital Account Supervisor at AgencyRx. Shane began the career at The CDM Group as a Business Development Coordinator and contributed to the Admissions Office at Saint Joseph's University as an Executive Board Member. Shane holds a BSBA in Pharmaceutical Marketing from Saint Joseph's University and has additional educational experience from the University of Galway and Brebeuf Jesuit Preparatory School.